Be Familiar With Evusheld for Prevention of COVID-19
June 2022
You'll hear about Evusheld (tixagevimab/cilgavimab), the first monoclonal antibody for PREVENTION of COVID-19.
Think of Evusheld as similar to casirivimab/imdevimab, sotrovimab, etc.
The big difference is that other COVID-19 "MAbs" are IV infusions for TREATMENT.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote